News

Padagis®, a Michigan-based leader in generic pharmaceuticals, announced today that the State of Michigan has added its over-the-counter (OTC) Naloxone HCl Nasal Spray 4 mg to the state's distribution ...
Lupin launches Ipratropium Bromide Nasal Solution in the US market; eyes expanding complex generics pipeline to over 200 ...
As respiratory illnesses like COVID-19, influenza, and Mycoplasma pneumonia continue to spread, the need for safe, ...
Lupin launches Ipratropium Bromide nasal spray in US, bioequivalent to Atrovent. The product addresses rhinitis and targets a $63 million market opportunity.
A psychedelic nasal spray requiring a much shorter period of clinical supervision has shown promise against ...
Mumbai: Global pharma major Lupin Limited has launched Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, in ...
Ritz crackers are being recalled for a labeling error that could be dangerous for people with peanut allergies.
Using LUCA's proprietary lipid nanocoating technology, the nasal spray demonstrated 99.7% antiviral efficacy within one minute in an in vitro third-party COVID-19 lab study overseas.
Shares of Evoke Pharma are trading sharply higher Wednesday morning. The specialty pharma company received a U.S. Patent ...
BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...
Lupin has announced the launch of Ipratropium Bromide Nasal Solution (nasal spray) in two strengths in the United States.